176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
5.72%
Revenue growth below 50% of MRVL's 11.65%. Michael Burry would check for competitive disadvantage risks.
6.71%
Cost growth 50-75% of MRVL's 13.37%. Bruce Berkowitz would examine sustainable cost advantages.
3.20%
Gross profit growth below 50% of MRVL's 10.19%. Michael Burry would check for structural issues.
-2.38%
Both companies show margin pressure. Martin Whitman would check industry conditions.
11.33%
R&D growth above 1.5x MRVL's 5.54%. Michael Burry would check for spending discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.42%
Operating expenses growth 1.1-1.25x MRVL's 8.16%. Bill Ackman would demand justification.
7.37%
Total costs growth 50-75% of MRVL's 10.72%. Bruce Berkowitz would examine efficiency.
No Data
No Data available this quarter, please select a different quarter.
16.48%
D&A growth while MRVL reduces D&A. John Neff would investigate differences.
69.30%
EBITDA growth exceeding 1.5x MRVL's 4.76%. David Dodd would verify competitive advantages.
19.39%
EBITDA margin growth while MRVL declines. John Neff would investigate advantages.
-37.64%
Operating income decline while MRVL shows 25.75% growth. Joel Greenblatt would examine position.
-41.01%
Operating margin decline while MRVL shows 12.63% growth. Joel Greenblatt would examine position.
-583.39%
Other expenses reduction while MRVL shows 10.01% growth. Joel Greenblatt would examine advantage.
-79.17%
Pre-tax income decline while MRVL shows 23.93% growth. Joel Greenblatt would examine position.
-80.30%
Pre-tax margin decline while MRVL shows 10.99% growth. Joel Greenblatt would examine position.
-131.98%
Tax expense reduction while MRVL shows 17.09% growth. Joel Greenblatt would examine advantage.
-73.68%
Net income decline while MRVL shows 26.89% growth. Joel Greenblatt would examine position.
-75.10%
Net margin decline while MRVL shows 13.65% growth. Joel Greenblatt would examine position.
-76.92%
EPS decline while MRVL shows 25.00% growth. Joel Greenblatt would examine position.
-75.00%
Diluted EPS decline while MRVL shows 14.29% growth. Joel Greenblatt would examine position.
0.89%
Share count reduction exceeding 1.5x MRVL's 3.06%. David Dodd would verify capital allocation.
-0.85%
Diluted share reduction while MRVL shows 4.10% change. Joel Greenblatt would examine strategy.